• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用DNA家族改组技术对一种细胞因子进行进化。

Evolution of a cytokine using DNA family shuffling.

作者信息

Chang C C, Chen T T, Cox B W, Dawes G N, Stemmer W P, Punnonen J, Patten P A

机构信息

Maxygen, Inc., 3410 Central Expressway, Santa Clara, CA 95051, USA.

出版信息

Nat Biotechnol. 1999 Aug;17(8):793-7. doi: 10.1038/11737.

DOI:10.1038/11737
PMID:10429246
Abstract

DNA shuffling of a family of over 20 human interferon-alpha (Hu-IFN-alpha) genes was used to derive variants with increased antiviral and antiproliferation activities in murine cells. A clone with 135,000-fold improved specific activity over Hu-IFN-alpha2a was obtained in the first cycle of shuffling. After a second cycle of selective shuffling, the most active clone was improved 285,000-fold relative to Hu-IFN-alpha2a and 185-fold relative to Hu-IFN-alpha1. Remarkably, the three most active clones were more active than the native murine IFN-alphas. These chimeras are derived from up to five parental genes but contained no random point mutations. These results demonstrate that diverse cytokine gene families can be used as starting material to rapidly evolve cytokines that are more active, or have superior selectivity profiles, than native cytokine genes.

摘要

通过对20多个人类α干扰素(Hu-IFN-α)基因家族进行DNA改组,在鼠细胞中获得了具有增强抗病毒和抗增殖活性的变体。在第一轮改组中获得了一个比Hu-IFN-α2a比活性提高了135,000倍的克隆。经过第二轮选择性改组后,活性最高的克隆相对于Hu-IFN-α2a提高了285,000倍,相对于Hu-IFN-α1提高了185倍。值得注意的是,三个活性最高的克隆比天然鼠α干扰素更具活性。这些嵌合体源自多达五个亲本基因,但没有随机点突变。这些结果表明,不同的细胞因子基因家族可以用作起始材料,以快速进化出比天然细胞因子基因更具活性或具有更优选择性的细胞因子。

相似文献

1
Evolution of a cytokine using DNA family shuffling.利用DNA家族改组技术对一种细胞因子进行进化。
Nat Biotechnol. 1999 Aug;17(8):793-7. doi: 10.1038/11737.
2
Directed evolution of gene-shuffled IFN-alpha molecules with activity profiles tailored for treatment of chronic viral diseases.通过定向进化获得基因改组的干扰素-α分子,其活性谱适合用于治疗慢性病毒性疾病。
Proc Natl Acad Sci U S A. 2007 May 15;104(20):8269-74. doi: 10.1073/pnas.0609001104. Epub 2007 May 9.
3
Biological characterization of three novel variants of IFN-alpha 13 produced by human placental trophoblast.人胎盘滋养层细胞产生的三种新型α-干扰素13变体的生物学特性
Placenta. 2001 Sep-Oct;22(8-9):673-80. doi: 10.1053/plac.2001.0706.
4
Characterization of gene expression profile in rat Kupffer cells stimulated with IFN-alpha or IFN-gamma.用α干扰素或γ干扰素刺激的大鼠库普弗细胞中基因表达谱的特征分析
Dig Liver Dis. 2006 Aug;38(8):563-77. doi: 10.1016/j.dld.2006.04.015. Epub 2006 Jun 27.
5
Characterization of the porcine alpha interferon multigene family.猪α干扰素多基因家族的特征分析
Gene. 2006 Nov 1;382:28-38. doi: 10.1016/j.gene.2006.06.013. Epub 2006 Jun 29.
6
DNA shuffling of a family of genes from diverse species accelerates directed evolution.对来自不同物种的一组基因进行DNA改组可加速定向进化。
Nature. 1998 Jan 15;391(6664):288-91. doi: 10.1038/34663.
7
The biological effects of five feline IFN-alpha subtypes.五种猫α干扰素亚型的生物学效应。
Vet Immunol Immunopathol. 2004 Jun;99(3-4):153-67. doi: 10.1016/j.vetimm.2004.01.012.
8
[DNA family shuffling of tissue-type plasminogen activator genes].[组织型纤溶酶原激活剂基因的DNA家族改组]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2003 Jan;19(1):97-9, 102.
9
Functional significance of globotriaosyl ceramide in interferon-alpha(2)/type 1 interferon receptor-mediated antiviral activity.葡萄糖神经酰胺在干扰素-α(2)/I型干扰素受体介导的抗病毒活性中的功能意义。
J Cell Physiol. 2000 Jan;182(1):97-108. doi: 10.1002/(SICI)1097-4652(200001)182:1<97::AID-JCP11>3.0.CO;2-Y.
10
Protein engineering of interferon alphas.α干扰素的蛋白质工程
Methods Mol Med. 2005;116:69-80. doi: 10.1385/1-59259-939-7:069.

引用本文的文献

1
Using a barcoded AAV capsid library to select for clinically relevant gene therapy vectors.使用带有条码的 AAV 衣壳文库筛选具有临床相关性的基因治疗载体。
JCI Insight. 2019 Nov 14;4(22):131610. doi: 10.1172/jci.insight.131610.
2
Constraint and Contingency Pervade the Emergence of Novel Phenotypes in Complex Metabolic Systems.约束与偶发性贯穿复杂代谢系统中新表型的出现过程。
Biophys J. 2017 Aug 8;113(3):690-701. doi: 10.1016/j.bpj.2017.06.034.
3
The IFN-λ-IFN-λR1-IL-10Rβ Complex Reveals Structural Features Underlying Type III IFN Functional Plasticity.
IFN-λ-IFN-λR1-IL-10Rβ复合物揭示了III型干扰素功能可塑性的结构特征。
Immunity. 2017 Mar 21;46(3):379-392. doi: 10.1016/j.immuni.2017.02.017.
4
Phenotypic innovation through recombination in genome-scale metabolic networks.通过基因组规模代谢网络中的重组实现表型创新。
Proc Biol Sci. 2016 Sep 28;283(1839). doi: 10.1098/rspb.2016.1536.
5
Design and evaluation of novel interferon lambda analogs with enhanced antiviral activity and improved drug attributes.具有增强抗病毒活性和改善药物特性的新型干扰素λ类似物的设计与评估。
Drug Des Devel Ther. 2016 Jan 6;10:163-82. doi: 10.2147/DDDT.S91455. eCollection 2016.
6
Construction and Immunogenicity Evaluation of Recombinant Influenza A Viruses Containing Chimeric Hemagglutinin Genes Derived from Genetically Divergent Influenza A H1N1 Subtype Viruses.包含源自基因差异较大的甲型H1N1亚型流感病毒嵌合血凝素基因的重组甲型流感病毒的构建及免疫原性评估
PLoS One. 2015 Jun 10;10(6):e0127649. doi: 10.1371/journal.pone.0127649. eCollection 2015.
7
Insights into cytokine-receptor interactions from cytokine engineering.细胞因子工程对细胞因子-受体相互作用的见解。
Annu Rev Immunol. 2015;33:139-67. doi: 10.1146/annurev-immunol-032713-120211. Epub 2014 Dec 10.
8
Broadening the heterologous cross-neutralizing antibody inducing ability of porcine reproductive and respiratory syndrome virus by breeding the GP4 or M genes.通过培育猪繁殖与呼吸综合征病毒的 GP4 或 M 基因来拓宽其诱导异种交叉中和抗体的能力。
PLoS One. 2013 Jun 24;8(6):e66645. doi: 10.1371/journal.pone.0066645. Print 2013.
9
Attenuation of porcine reproductive and respiratory syndrome virus by molecular breeding of virus envelope genes from genetically divergent strains.通过对遗传分化株的病毒囊膜基因进行分子育种来减弱猪繁殖与呼吸综合征病毒。
J Virol. 2013 Jan;87(1):304-13. doi: 10.1128/JVI.01789-12. Epub 2012 Oct 17.
10
Algorithms for optimizing cross-overs in DNA shuffling.DNA 重排中交叉优化算法。
BMC Bioinformatics. 2012 Mar 21;13 Suppl 3(Suppl 3):S3. doi: 10.1186/1471-2105-13-S3-S3.